10 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga·03/02/2026 12:05:44
Listen to the news
Gainers
Icecure Medical (NASDAQ:ICCM) shares moved upwards by 17.7% to $0.68 during Monday's pre-market session. The market value of their outstanding shares is at $39.8 million.
Precigen (NASDAQ:PGEN) shares rose 8.17% to $4.1. The company's market cap stands at $1.3 billion.
RadNet (NASDAQ:RDNT) stock increased by 7.44% to $75.01. The market value of their outstanding shares is at $5.4 billion. As per the press release, Q4 earnings came out today.
Skye Bioscience (NASDAQ:SKYE) shares increased by 7.39% to $0.8. The market value of their outstanding shares is at $23.8 million.
Losers
Aardvark Therapeutics (NASDAQ:AARD) shares declined by 54.8% to $5.65 during Monday's pre-market session. The market value of their outstanding shares is at $271.9 million.
uniQure (NASDAQ:QURE) shares fell 51.7% to $7.55. The market value of their outstanding shares is at $973.6 million. As per the press release, Q4 earnings came out today.
Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares decreased by 16.34% to $5.48. The company's market cap stands at $11.9 million.
Ensysce Biosciences (NASDAQ:ENSC) shares declined by 16.24% to $0.52. The market value of their outstanding shares is at $2.2 million.
Alzamend Neuro (NASDAQ:ALZN) shares fell 15.43% to $1.7. The market value of their outstanding shares is at $7.6 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.